Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate for Toxoplasma-Exposed Schizophrenia
NCT02011750Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Apr 2013
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valproic acid in schizophrenia, sponsored by University of Pittsburgh. Started Apr 2013; status: completed.
02
Drugs
valproic acid
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02011750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02011750.